Synonyms:alfuzosin, 81403-80-7, Alfuzosina, Alfuzosine, Alfuzosinum, SL 77499, ALFLUZOCIN, ALFLUZOSIN, Alfuzosin (INN), N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide, CHEMBL709, NSC-760065, CHEBI:51141, 90347YTW5F, N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide, N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide, Alfuzosine [French], Alfuzosinum [Latin], Alfusosine, ALFUZOSIN [INN], Alfuzosina [Spanish], Alfuzosin [INN:BAN], 2-Furancarboxamide,N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-, SL 77499-10, N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide, N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}oxolane-2-carboxamide, SMR000466340, Xatral (TN), HSDB 7290, SL 77-499, SL-7749910, UNII-90347YTW5F, N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl), SR-01000759345, Alfuzosin- Bio-X, Alfuzosin-[d7], n-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)tetrahydrofuran-2-carboxamide, ALFUZOSIN [MI], ALFUZOSIN [HSDB], Prestwick0_000322, Prestwick1_000322, Prestwick2_000322, Prestwick3_000322, Spectrum2_000505, Spectrum3_001063, Spectrum4_001208, Spectrum5_000817, ALFUZOSIN [VANDF], ALFUZOSIN [WHO-DD], SCHEMBL34477, BSPBio_000323, BSPBio_002646, KBioGR_001616, MLS000759449, MLS001424027, MLS006011887, SPECTRUM1505263, SPBio_000429, SPBio_002244, BPBio1_000357, GTPL7109, DTXSID6048549, KBio3_001866, HMS1922P11, HMS2051I10, HMS2093O06, HMS2235O22, HMS3369K03, HMS3393I10, HMS3749I05, HMS3886O22, Pharmakon1600-01505263, ACT03219, HY-B0192, BDBM50033110, CCG-39585, MFCD00865792, NSC760065, s5766, STK643675, AKOS005574697, CCG-100859, DB00346, NC00109, NSC 760065, SDCCGSBI-0206735.P002, NCGC00095152-01, NCGC00095152-02, NCGC00095152-03, NCGC00095152-04, NCGC00095152-05, NCGC00095152-07, NCGC00095152-19, 2-Furancarboxamide, N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-, BA164145, MS-26479, SBI-0206735.P001, DB-056523, AB00514667, FT-0630891, D07124, F84998, AB00514667-07, AB00514667-09, AB00514667-10, AB00514667_11, AB00514667_12, (methyl)amino)propyl)tetrahydrofuran-2-carboxamide, A840122, EN300-19766666, L001317, Q2736873, SR-01000759345-4, BRD-A09056319-001-02-2, BRD-A09056319-001-05-5, BRD-A09056319-003-03-6, (+/-)-N-(3-((4-AMINO-6,7-DIMETHOXYQUINAZOLIN-2-YL)(METHYL)AMINO)PROPYL)TETRAHYDROFURAN-2-CARBOXAMIDE, (+/-)-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide, 1100050-87-0, 2-FURANCARBOXAMIDE, (+/-)-N-(3-((4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)METHYLAMINO)PROPYL)TETRAHYDRO-, N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide, N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino]propyl]tetrahydrofuran-2-carboxamide;Alfuzosin, N-{3-[(4-imino-6,7-dimethoxy-3,4-dihydroquinazolin-2-yl)(methyl)amino]propyl}oxolane-2-carboximidic acid
Pubchem:PUBCHEM:2092
Id:7ba407ac-bfce-586e-ae4a-4d116145fec4
Description:nan
